| Greenberg, Benjamin |
NCT00640133: Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder |
|
|
| Active, not recruiting | 4 | 27 | US | Active DBS, Activa Deep Brain Stimulation System (Medtronic, Inc.), Implantable Neurostimulator (INS), Sham DBS | Butler Hospital, National Institute of Mental Health (NIMH) | Obsessive-Compulsive Disorder | 05/18 | 12/24 | | |
BEAT-MS, NCT04047628: Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis |
|
|
| Recruiting | 3 | 156 | US | Autologous Hematopoietic Stem Cell Transplantation, AHSCT, Best Available Therapy (BAT), natalizumab (Tysabri®), alemtuzumab (Campath®, Lemtrada®), ocrelizumab (Ocrevus®), rituximab (Rituxan®), cladribine (Mavenclad®), ofatumumab (Kesimpta®), ublituximab (BRIUMVI™) | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), Blood and Marrow Transplant Clinical Trials Network, PPD DEVELOPMENT, LP, Rho Federal Systems Division, Inc. | Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | 10/26 | 10/29 | | |
REPAIR-MS, NCT03993171: 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis. |
|
|
| Active, not recruiting | 2 | 30 | US | gold nanocrystals, CNM-Au8 | Clene Nanomedicine, University of Texas Southwestern Medical Center | Multiple Sclerosis | 04/25 | 06/25 | | |
REVEAL, NCT05606614: Safety and Efficacy of TSHA-102 in Adolescent and Adult Females with Rett Syndrome ( Adult Study) |
|
|
| Recruiting | 1/2 | 18 | Canada, US | TSHA-102 | Taysha Gene Therapies, Inc. | Rett Syndrome | 01/25 | 01/32 | | |
NCT03887273: Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis |
|
|
| Recruiting | 1/2 | 9 | US | Q-Cells, glial restricted progenitor cells | Q Therapeutics, Inc. | Transverse Myelitis | 07/24 | 12/24 | | |
| Recruiting | 1 | 20 | US | Light therapy | University of Texas Southwestern Medical Center, National Multiple Sclerosis Society, International Progressive Multiple Sclerosis Alliance | Progressive Multiple Sclerosis | 05/25 | 12/25 | | |
| Completed | 1 | 33 | US | ANK-700, Placebo | Anokion SA | Multiple Sclerosis (MS), Relapsing Remitting Multiple Sclerosis | 04/24 | 04/24 | | |
| Active, not recruiting | 1 | 4 | US | AAV9/CLN7 | Benjamin Greenberg | CLN7 | 02/28 | 02/29 | | |
SONICS, NCT03942952: PEDIATRIC Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes. |
|
|
| Completed | N/A | 49 | US | | University of Texas Southwestern Medical Center | Multiple Sclerosis, Relapsing-Remitting, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Transverse Myelitis | 06/23 | 06/23 | | |
NCT06163508: A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells |
|
|
| Enrolling by invitation | N/A | 9 | US | Q-Cells® | University of Texas Southwestern Medical Center | Transverse Myelitis | 12/35 | 12/35 | | |
NCT01623076: The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders |
|
|
| Recruiting | N/A | 150 | US | | University of Texas Southwestern Medical Center | Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Transverse Myelitis, Optic Neuritis | 06/25 | 06/25 | | |
NCT00445367: Biobank For MS And Other Demyelinating Diseases |
|
|
| Active, not recruiting | N/A | 3226 | US | | Accelerated Cure Project for Multiple Sclerosis | Multiple Sclerosis, Transverse Myelitis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Optic Neuritis | 10/26 | 10/36 | | |
| Pascual, Juan |
NCT03301532: Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D |
|
|
| Completed | 2 | 10 | US | Triheptanoin, C7 oil | University of Texas Southwestern Medical Center, National Institute of Neurological Disorders and Stroke (NINDS) | GLUT1DS1 | 06/21 | 07/22 | | |
NCT03181399: Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) |
|
|
| Active, not recruiting | 2 | 45 | US | Triheptanoin, C7 | University of Texas Southwestern Medical Center, National Institute of Neurological Disorders and Stroke (NINDS) | GLUT1DS1, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Metabolism Disorders, Glucose Transport Defect, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome | 09/24 | 09/24 | | |
| No Longer Available | N/A | | US | Triheptanoin, C7 oil, Heptanoate, heptanoic acid | Juan Pascual | Glut1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome | | | | |
| Recruiting | N/A | 40 | Europe | Dialectical Behavioral Therapy Skills Training, DBT-ST, EMDR | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, EMDR Europe | Borderline Personality Disorder, Trauma | 05/23 | 05/23 | | |
OUTCOMES, NCT05343962: Health Indicators and Patient Reported Outcomes. Identification of Significative Items Aimed at Improving Health Care Procceses. |
|
|
| Recruiting | N/A | 250 | Europe | | Instituto de Biomecanica de Valencia, Asociación Parkinson Valencia (https://www.parkinson-valencia.com/), Asociación Valenciana de Diabetes (https://www.avdiabetes.org/), Hospital General Universitario de Valencia | Parkinson Disease, Diabetes Mellitus, COVID-19, Chronic Obstructive Pulmonary Disease (COPD), Stroke | 07/23 | 12/23 | | |
NCT04137692: Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome |
|
|
| Active, not recruiting | N/A | 5 | US | Red Blood Cell Transfusion | Juan Pascual | Glucose Transporter Type 1 Deficiency Syndrome, GLUT1DS1 | 10/28 | 10/28 | | |
DBT+Context, NCT05972096: DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder |
|
|
| Recruiting | N/A | 60 | Europe | Combination DBT, self-compassion and contextual-based skills | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Borderline Personality Disorders, BPD | 10/23 | 10/23 | | |
NCT01668082: An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection |
|
|
| Recruiting | N/A | 40 | US | surgical resection of a brain tumor | University of Texas Southwestern Medical Center | Brain Mass | 02/26 | 02/27 | | |
NCT02013583: The Glucose Transporter Type I Deficiency (G1D) Registry |
|
|
| Recruiting | N/A | 750 | US | No intervention | University of Texas Southwestern Medical Center | GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter type1 (GLUT-1) Deficiency, GLUT-1 Deficiency Syndrome | 12/32 | 12/32 | | |
| Avila, Adrian |
| Recruiting | N/A | 20 | US | Magnetic resonance imaging, MRI | University of Texas Southwestern Medical Center | Glut1 Deficiency Syndrome 1, Glucose Metabolism Disorders, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome, Glucose Transport Defect | 09/26 | 09/26 | | |
| Plumb, Tricia |
| Recruiting | 2 | 15 | Europe, Canada, US, RoW | Inebilizumab | Amgen, Horizon Therapeutics Ireland DAC | Neuromyelitis Optica Spectrum Disorder | 04/27 | 04/27 | | |
